BACKGROUND: With diffusion-tensor imaging (DTi) it is possible to estimate the structural characteristics of fiber bundles in vivo. This study used DTi to infer damage to the corticospinal tract (CST) and relates this parameter to (a) the level of residual motor ability at least 1 year poststroke and (b) the outcome of intensive motor rehabilitation with constraint-induced movement therapy (CIMT). OBJECTIVE: To explore the role of CST damage in recovery and CIMT efficacy. METHODS: Ten patients with low-functioning hemiparesis were scanned and tested at baseline, before and after CIMT. Lesion overlap with the CST was indexed as reduced anisotropy compared with a CST variability map derived from 26 controls. Residual motor ability was measured through the Wolf Motor Function Test (WMFT) and the Motor Activity Log (MAL) acquired at baseline. CIMT benefit was assessed through the pre-post treatment comparison of WMFT and MAL performance. RESULTS: Lesion overlap with the CST correlated with residual motor ability at baseline, with greater deficits observed in patients with more extended CST damage. Infarct volume showed no systematic association with residual motor ability. CIMT led to significant improvements in motor function but outcome was not associated with the extent of CST damage or infarct volume. CONCLUSION: The study gives in vivo support for the proposition that structural CST damage, not infarct volume, is a major predictor for residual functional ability in the chronic state. The results provide initial evidence for positive effects of CIMT in patients with varying, including more severe, CST damage.
BACKGROUND: With diffusion-tensor imaging (DTi) it is possible to estimate the structural characteristics of fiber bundles in vivo. This study used DTi to infer damage to the corticospinal tract (CST) and relates this parameter to (a) the level of residual motor ability at least 1 year poststroke and (b) the outcome of intensive motor rehabilitation with constraint-induced movement therapy (CIMT). OBJECTIVE: To explore the role of CST damage in recovery and CIMT efficacy. METHODS: Ten patients with low-functioning hemiparesis were scanned and tested at baseline, before and after CIMT. Lesion overlap with the CST was indexed as reduced anisotropy compared with a CST variability map derived from 26 controls. Residual motor ability was measured through the Wolf Motor Function Test (WMFT) and the Motor Activity Log (MAL) acquired at baseline. CIMT benefit was assessed through the pre-post treatment comparison of WMFT and MAL performance. RESULTS: Lesion overlap with the CST correlated with residual motor ability at baseline, with greater deficits observed in patients with more extended CST damage. Infarct volume showed no systematic association with residual motor ability. CIMT led to significant improvements in motor function but outcome was not associated with the extent of CST damage or infarct volume. CONCLUSION: The study gives in vivo support for the proposition that structural CST damage, not infarct volume, is a major predictor for residual functional ability in the chronic state. The results provide initial evidence for positive effects of CIMT in patients with varying, including more severe, CST damage.
Authors: Josep Puig; Gerard Blasco; Gottfried Schlaug; Cathy M Stinear; Pepus Daunis-I-Estadella; Carles Biarnes; Jaume Figueras; Joaquín Serena; Maria Hernández-Pérez; Angel Alberich-Bayarri; Mar Castellanos; David S Liebeskind; Andrew M Demchuk; Bijoy K Menon; Götz Thomalla; Kambiz Nael; Max Wintermark; Salvador Pedraza Journal: Neuroradiology Date: 2017-03-14 Impact factor: 2.804
Authors: Alex R Carter; Kevin R Patel; Serguei V Astafiev; Abraham Z Snyder; Jennifer Rengachary; Michael J Strube; Anna Pope; Joshua S Shimony; Catherine E Lang; Gordon L Shulman; Maurizio Corbetta Journal: Neurorehabil Neural Repair Date: 2011-07-29 Impact factor: 3.919
Authors: Ibrahim Ibrahim; Jaroslav Tintera; Antonin Skoch; Filip Jirů; Petr Hlustik; Patricia Martinkova; Karel Zvara; Kamila Rasova Journal: Neuroradiology Date: 2011-05-10 Impact factor: 2.804
Authors: Mark G Bowden; Andrea L Behrman; Michelle Woodbury; Chris M Gregory; Craig A Velozo; Steven A Kautz Journal: J Neurol Phys Ther Date: 2012-03 Impact factor: 3.649
Authors: Adrian G Guggisberg; Philipp J Koch; Friedhelm C Hummel; Cathrin M Buetefisch Journal: Clin Neurophysiol Date: 2019-04-15 Impact factor: 3.708
Authors: Maria A Rocca; Anna C Turconi; Sandra Strazzer; Martina Absinta; Paola Valsasina; Elena Beretta; Massimiliano Copetti; Monica Cazzagon; Andrea Falini; Massimo Filippi Journal: Neurotherapeutics Date: 2013-07 Impact factor: 7.620